Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC) and hepatic decompensation among patients with chronic liver disease (CLD). Statins, particularly ...
Research conducted across multiple institutions, including the University of Southern California, University of Hawaii, and Harvard T.H. Chan School of Public Health reported that healthier lifestyle and dietary behaviors ...
Higher adherence to the Mediterranean diet is associated with a modest reduction in the risk of obesity-related cancers, according to research conducted by the European Prospective Investigation Into Cancer and Nutrition ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC), potentially delaying disease ...
Researchers at the University of California San Diego have found an unusual ally in the quest to make cancer diagnosis faster, more accurate and more accessible worldwide: the Morpho butterfly. Known for its shimmering blue ...
Feb 20, 2025
0
36
Researchers have discovered that stomach cancers make electrical connections with nearby sensory nerves and use these malignant circuits to stimulate the cancer's growth and spread.
Feb 19, 2025
0
55
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis.
Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently more than 300,000 new cases and 200,000 deaths annually, according to data from the World Health ...
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune system. It essentially hacks the immune cells, transferring its own faulty mitochondrial DNA (mtDNA) ...
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin following standard adjuvant therapy for high-risk Dukes' B and C colorectal cancer did not yield a significant ...
